Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the impact of adjunctive cilostazol versus high
maintenance-dose clopidogrel on platelet inhibition in carriers and non-carriers of the
loss-of-function CYP2C19 mutant allele.